Forty-six state attorneys general filed a lawsuit in Connecticut, June 10, against 26 drug manufacturers and 10 individuals for “conspiracy to allocate markets and fix prices for multiple generic drugs.”
The 543-page lawsuit (pdf) accuses the companies of fixing prices from at least 2009 through early 2016 on a wide range of products that include Ritalin, used to treat attention deficit disorder, attention hyperactivity disorder, and some sleep disorders.
